Petros Pharmaceuticals Stock Market Value
| PTPI Stock | USD 0.01 0.0005 6.25% |
| Symbol | Petros |
Petros Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Petros Pharmaceuticals' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Petros Pharmaceuticals.
| 12/07/2025 |
| 01/06/2026 |
If you would invest 0.00 in Petros Pharmaceuticals on December 7, 2025 and sell it all today you would earn a total of 0.00 from holding Petros Pharmaceuticals or generate 0.0% return on investment in Petros Pharmaceuticals over 30 days. Petros Pharmaceuticals is related to or competes with Shineco, INVO Fertility, Lixte Biotechnology, Celularity, Longevity Health, Concord Medical, and PetVivo Holdings. Petros Pharmaceuticals, Inc., a pharmaceutical company, focuses on mens health therapeutics More
Petros Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Petros Pharmaceuticals' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Petros Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.13) | |||
| Maximum Drawdown | 55.0 | |||
| Value At Risk | (18.18) | |||
| Potential Upside | 15.79 |
Petros Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Petros Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Petros Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Petros Pharmaceuticals historical prices to predict the future Petros Pharmaceuticals' volatility.| Risk Adjusted Performance | (0.08) | |||
| Jensen Alpha | (1.36) | |||
| Total Risk Alpha | (2.56) | |||
| Treynor Ratio | (3.20) |
Petros Pharmaceuticals Backtested Returns
Petros Pharmaceuticals maintains Sharpe Ratio (i.e., Efficiency) of -0.13, which implies the firm had a -0.13 % return per unit of risk over the last 3 months. Petros Pharmaceuticals exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Petros Pharmaceuticals' Coefficient Of Variation of (797.50), variance of 110.69, and Risk Adjusted Performance of (0.08) to confirm the risk estimate we provide. The company holds a Beta of 0.42, which implies possible diversification benefits within a given portfolio. As returns on the market increase, Petros Pharmaceuticals' returns are expected to increase less than the market. However, during the bear market, the loss of holding Petros Pharmaceuticals is expected to be smaller as well. At this point, Petros Pharmaceuticals has a negative expected return of -1.32%. Please make sure to check Petros Pharmaceuticals' value at risk, daily balance of power, as well as the relationship between the Daily Balance Of Power and period momentum indicator , to decide if Petros Pharmaceuticals performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.24 |
Weak reverse predictability
Petros Pharmaceuticals has weak reverse predictability. Overlapping area represents the amount of predictability between Petros Pharmaceuticals time series from 7th of December 2025 to 22nd of December 2025 and 22nd of December 2025 to 6th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Petros Pharmaceuticals price movement. The serial correlation of -0.24 indicates that over 24.0% of current Petros Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.24 | |
| Spearman Rank Test | 0.2 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Petros Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Petros Pharmaceuticals pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Petros Pharmaceuticals' pink sheet expected returns. We can calculate the autocorrelation of Petros Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Petros Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Petros Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Petros Pharmaceuticals pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Petros Pharmaceuticals pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Petros Pharmaceuticals pink sheet over time.
Current vs Lagged Prices |
| Timeline |
Petros Pharmaceuticals Lagged Returns
When evaluating Petros Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Petros Pharmaceuticals pink sheet have on its future price. Petros Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Petros Pharmaceuticals autocorrelation shows the relationship between Petros Pharmaceuticals pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Petros Pharmaceuticals.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Other Information on Investing in Petros Pink Sheet
Petros Pharmaceuticals financial ratios help investors to determine whether Petros Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Petros with respect to the benefits of owning Petros Pharmaceuticals security.